- 10 February 2026
IF YOU PRESCRIBE SUBSCRIBE
If you're a health professional, subscribe to receive regular email updates from Australian Prescriber
-
Volume 49 Issue 1
February 2026 - February 2026
Article
Supporting the appropriate use of psychotropic medicines in aged and disability care
Stephen Macfarlane, Julian N Trollor, Rebecca Koncz, Maria Sukkar, Carolyn Hullick
- 10 February 2026
-
Article
Pharmacological management of attention deficit hyperactivity disorder in adults
Shuichi Suetani, Jaimie Hull, James G Scott
- 10 February 2026
-
Article
Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis: is it effective?
Huai Leng Pisaniello, Shyan Goh, Rachelle Buchbinder
- 10 February 2026
-
Article
Preventing infections in immunosuppressed patients
Aadith Ashok, Aleece I Macphail, Michelle L Giles, Bradley J Gardiner
- 10 February 2026
-
Article
Secondary prevention of acute coronary syndromes: a summary of the new 2025 Australian guideline
Jasmine Just, David Brieger, Alexandra Bennett, Tom Briffa
- 10 February 2026
-
TGA Medicines Safety Update summary
Strengthened warnings for fracture risk after discontinuation of denosumab (Prolia and biosimilars)
- 10 February 2026
TGA Medicines Safety Update summary
Glucagon-like peptide-1 receptor agonists: warnings aligned over potential risk of suicidal thoughts or behaviours
- 10 February 2026
TGA Medicines Safety Update summary
Updated contraception advice for Mounjaro (tirzepatide)
- 10 February 2026
NEW DRUGS
Ivosidenib for cholangiocarcinoma and acute myeloid leukaemia
- 10 February 2026
Vutrisiran for transthyretin amyloidosis
- 10 February 2026
IF YOU PRESCRIBE SUBSCRIBE
If you're a health professional, subscribe to receive regular email updates from Australian Prescriber
